Astonea Labs BSE SME

Astonea Labs SME IPO

Listed

BSE SMEOpens 27 May 2025Closes 29 May 2025

Founded in 2017, Astonea Labs Ltd. specializes in contract manufacturing of pharmaceutical and cosmetic products for both domestic and international clients. The company produces a wide range of medicines including…

Show more
Price band
₹128.00 - 135.00
Issue size
₹37.67 Cr
Lot size
1,000 shares
Type
BSE SME
GMP
₹0 (0.0%)
Est. listing
₹135
Est. profit / app
—
Retail quota
—

Key ratios

As per RHP / filings
Face value
₹10
EPS
5.2
P/E ratio
25.94
RoNW
31.83%
ROE
37.86%
Debt / Equity
2.16
Advertisement

Timeline

  1. IPO Opens

    27 May 2025

  2. IPO Closes

    29 May 2025

  3. Allotment

    30 May 2025

  4. Listing

    3 Jun 2025

IPO Timeline & Listing Details

EventDate
IPO Open Date27 May 2025
IPO Close Date29 May 2025
Allotment Date30 May 2025
Listing Date3 June 2025

Investment Categories

CategoryLotsAmount
Individual
2₹2,70,000
SHNI (Min)
3₹4,05,000
SHNI (Max)
7₹9,45,000
BHNIAbove ₹10,00,000
8₹10,80,000

IPO Objectives

  • Funding of expenses proposed to be incurred towards registration in Bolivia, South America
  • Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises
  • Advertising, marketing and brand building
  • Investment in procuring hardware and software
  • Funding of working capital requirements
  • General corporate purposes.

Strengths

  • Robust marketing and distribution network supports both domestic and international operations.
  • Seasoned management team with strong expertise in the pharmaceutical and cosmetics industries.
  • Expanding and diverse product portfolio across pharma and cosmetic verticals.
  • High-quality, innovative offerings provide a competitive advantage in niche segments.

Weaknesses

  • Requires significant funding to scale operations at a national level.
  • Market share remains limited in several key product segments.
  • Highly influenced by market trends and intense industry competition.
  • Vulnerable to pricing pressure from established local and global competitors.
Advertisement

Financial Performance

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets (₹ Cr.)96.5280.8964.2852.91
Revenue (₹ Cr.)69.6980.2967.2630.17
PAT (₹ Cr.)4.13.810.670.25
Net Worth (₹ Cr.)17.2811.978.167.49

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)
Astonea Labs Ltd925.9431.83%17.28
Beta Drugs Limited11.394923.19%157

Subscription Details

Daily Bids Status

CategoryDay 1Day 2Day 3
QIB0x0.11x0.7x
NII0.65x2.28x5.6x
RII0.35x0.68x1.68x
Total0.22x0.64x1.78x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB13,20,0009,27,00012.51
NII3,99,00022,33,00030.15
RII9,27,00015,53,00020.97
Total26,46,00047,13,00063.63
Advertisement

Company Details

  • Astonea Labs
  • House No. 1358, 1st Floor, Sector-22B, Chandigarh, 160022
  • +91 9888302323
  • cs@astonea.org
  • https://www.astonea.org/

Registrar Details

Frequently Asked Questions

See live numbers on GMP, Subscription, and Allotment pages.

Astonea Labs SME IPO News & Updates

Follow the latest updates for Astonea Labs SME IPO, including grey market moves and allotment news.

Astonea Labs SME IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Sources

We match Astonea Labs SME IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • Kfin Technologies LimitedOfficial site to check allotment status for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.

Loading comments...